Merck welcomes independent review of the safety profile of JANUVIA® (sitagliptin)
12 June 2013 | By Merck
"Nothing is more important to Merck than the safety of our medicines..."
List view / Grid view
News
AbbVie presents first study assessing the role of predefined doses of methotrexate when used in combination with HUMIRA® (adalimumab) for RA
12 June 2013 | By AbbVie
Results from the CONCERTO trial...
Abbott initiates randomized clinical trial in Japan to evaluate the Absorb™ Bioresorbable Vascular Scaffold
11 June 2013 | By Abbott
Trial to study the innovative "dissolving" heart device...
New four-strain influenza vaccine from Sanofi Pasteur now licensed by FDA for broad age range of children and adults
10 June 2013 | By Sanofi Pasteur
“Sanofi Pasteur is committed to providing new immunization options..."
Roche’s RoACTEMRA approved in EU to treat children with rare form of arthritis
10 June 2013 | By Roche
“This approval comes earlier than expected, just one month following the positive CHMP opinion...”
Switching to Novartis drug Gilenya from standard interferon shown to improve long-term outcomes for patients with MS
10 June 2013 | By Novartis
Two new analyses from the Phase III TRANSFORMS study presented...
AstraZeneca to acquire Pearl Therapeutics to strengthen respiratory portfolio
10 June 2013 | By AstraZeneca
AstraZeneca has entered into a definitive agreement to acquire Pearl Therapeutics...
Boehringer Ingelheim’s investigational faldaprevir+ achieved viral cure in 88% of treatment-naïve hepatitis C patients in Asia
8 June 2013 | By Boehringer Ingelheim
New findings presented...
Gilead announces U.S. FDA priority review designation for sofosbuvir for the treatment of hepatitis C
7 June 2013 | By Gilead Sciences
Gilead Sciences announced that the U.S. FDA has granted priority review...
Boehringer Ingelheim pioneers biopharmaceuticals move to China
6 June 2013 | By Boehringer Ingelheim
Boehringer Ingelheim has signed with Zhangjiang Biotech & Pharmaceutical Base Development Company...
GSK statement in response to FDA Advisory Committee’s vote on availability of Avandia (rosiglitazone)
6 June 2013 | By GlaxoSmithKline
A joint advisory committee to the U.S. FDA voted to continue to make Avandia available...
GGC reports autism discovery
5 June 2013 | By Greenwood Genetic Center
Researchers have reported an important discovery in the understanding of autism which was published this week in Molecular Autism...
ORIGIN results on Lantus® cardiovascular safety integrated into European Union product label
5 June 2013 | By Sanofi
ORIGIN was a landmark, seven-year clinical trial...
New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
5 June 2013 | By Novartis
Gilenya improved the key measures...
U.S. FDA grants priority review for Metreleptin
4 June 2013 | By Bristol-Myers Squibb Company
Metreleptin, an investigational agent for treatment of metabolic disorders associated with rare forms of LD...
